The US Food and Drug Administration has approved the Boostrix vaccine, currently available for adolescents and adults, for use in people 65 years and older for the prevention of tetanus, diphtheria and pertussis. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
